Know Cancer

or
forgot password

Prospective Cohort Study With Risk-adapted Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma


N/A
20 Years
N/A
Open (Enrolling)
Both
Diffuse Large B-cell Lymphoma

Thank you

Trial Information

Prospective Cohort Study With Risk-adapted Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma


We dichotomize patients according to the risk of CNS involvement. Then, we perform CNS
evaluation in patients at risk of CNS involvement. We prospectively monitor whether CNS
relapse or metastasis occurs in patients with diffuse large B-cell lymphoma


Inclusion Criteria:



1. Newly diagnosed patients with diffuse large B cell lymphoma

2. > 20 years

3. life expectancy more than 6 months

4. Written informed consent

Exclusion Criteria:

1. Refusal to informed consent

2. Lymphomas other than diffuse large B cell lymphoma

3. Primary CNS lymphoma

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

CNS relapse/involvement

Outcome Description:

After enrollment, patients will be monitored to check the CNS relapse or involvement

Outcome Time Frame:

Up to 2 years after participants are enrolled.

Safety Issue:

No

Principal Investigator

Cheolwon Suh, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Consortium for Improving Survival of Lymphoma

Authority:

Korea: Institutional Review Board

Study ID:

2010-04-091

NCT ID:

NCT01202448

Start Date:

August 2010

Completion Date:

December 2014

Related Keywords:

  • Diffuse Large B-Cell Lymphoma
  • Diffuse large B cell lymphoma
  • central nervous system
  • prognosis
  • Lymphoma
  • Lymphoma, B-Cell
  • Lymphoma, Large B-Cell, Diffuse

Name

Location